AI assistant
Novonesis AS — Director's Dealing 2012
Jan 26, 2012
3377_rpt_2012-01-26_0c879fea-2b9f-4c02-9140-9f5066592866.pdf
Director's Dealing
Open in viewerOpens in your device viewer
January 26, 2011
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Name | Relation/ Category of close relation |
Trading date | Character of transaction |
Volume of transaction Buy (+) / Sell (-) |
Value of trans action (DKK) |
|---|---|---|---|---|---|
| Benny D. Loft | EVP, and CFO | 26/1/2012 | Exercise of Options (purchase of shares) |
+189,120 | 14,751,360 |
| Contact persons: | |||
|---|---|---|---|
| Press and media: | Investor relations: | ||
| René Tronborg (Europe) | Martin Riise | ||
| Tel. (direct): +45 4446 2274 | |||
| Tel. (mobile): +45 3077 2274 | |||
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Martin Riise Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27